July 8, 2015 by Steve Levine

Zofran: A Pregnant Woman’s Best Friend?

In America, we’re quick to find a prescription drug to cure any ailment we may have. While some medications are a necessity, others are merely a Band-Aid that may come with adverse side effects. One disturbing drug is Zofran (Ondansetron), a medication prescribed off-label by doctors to treat pregnant women suffering with morning sickness during…

Continue Reading »

June 10, 2015 by Steve Levine

Is Xarelto Litigation the New Pradaxa?

Mass tort attorneys across the U.S. are gearing up for new blood thinner litigation with particular relish, even by injury lawyer standards. Xarelto, the blockbuster blood thinner drug with the deep pockets of Johnson & Johnson behind it, is firmly in their crosshairs. One of the most attractive traits of litigating this one is it’s…

Continue Reading »

April 10, 2015 by Steve Levine

Drug Maker Mylan Bids To Takeover Rival Perrigo

Pharmaceutical giant Perrigo has been expanding through acquisition for several years. Now it appears as if it may be acquired by rival drug firm Mylan. Mylan originally announced its bid proposal on April 8, 2015 in a press release. The bid would create a $29 billion company that will dominate generic and over-the-counter medications. The…

Continue Reading »

March 31, 2015 by Steve Levine

Lawsuits Rising For Zofran Related Birth Defects

Zofran (ondansetron) was first approved to treat severe nausea in cancer patients by the U.S. Food and Drug Administration (FDA) in. This prescription medication was then prescribed to pregnant women experiencing morning sickness usually during the first trimester. It appears that with recent studies, Zofran may come with serious side effects for both mother and…

Continue Reading »

1 2 3